Podiatrists in Rego Park, NY Accepting Medicare

26 Podiatrists found. Showing 21 - 26

Anthony Orlando, DPM Podiatrist - Foot Surgery Medicare: Accepting Medicare Assignments Practice Location: 6741 Woodhaven Blvd, Rego Park, NY 11374 Phone: 718-459-9575    Fax: 718-459-9548

David Mahgerefteh Podiatrist Medicare: Not Enrolled in Medicare Practice Location: 9909 67th Ave, Rego Park, NY 11374 Phone: 718-997-9633

Dt Foot Care Pc Podiatrist Medicare: Medicare Enrolled Practice Location: 9314 Queens Blvd, 1e, Rego Park, NY 11374 Phone: 718-275-7600

Erb Podiatry, P.c. Podiatrist Medicare: Medicare Enrolled Practice Location: 9876 Queens Blvd, Suite 1c, Rego Park, NY 11374 Phone: 718-830-3239    Fax: 718-830-3839

Dr. David Abraham Katz, D.P.M Podiatrist - Foot & Ankle Surgery Medicare: Accepting Medicare Assignments Practice Location: 9811 Queens Blvd, Suite 1a, Rego Park, NY 11374 Phone: 718-830-0400

Dr. Hal Fredric Abrahamson, D.P.M. Podiatrist - Primary Podiatric Medicine Medicare: Not Enrolled in Medicare Practice Location: 9707 63rd Rd, Rego Park, NY 11374 Phone: 718-896-4433    Fax: 718-896-4747

News Archive

Blood expression levels of genes targeted by stress hormones could be biomarker for developing PTSD

Blood expression levels of genes targeted by the stress hormones called glucocorticoids could be a physical measure, or biomarker, of risk for developing Post-Traumatic Stress Disorder (PTSD), according to a study conducted in rats by researchers at the Icahn School of Medicine at Mount Sinai and published August 11 in Proceedings of the National Academy of Sciences (PNAS).

Gambro acquires CHF Solutions

Gambro and CHF Solutions, Inc. (CHF) announced today that Gambro has acquired CHF, a medical device company that manufactures and distributes ultrafiltration devices to treat fluid overload.

Secretome of pleural effusions linked to NSCLC and malignant mesothelioma

Cryopreserved cell-free PE fluid from 101 NSCLC patients, 8 mesothelioma and 13 with benign PE was assayed for a panel of 40 cytokines/chemokines using the Luminex system.

PR Pharmaceuticals issued U.S. patent covering 2-methoxyestradiol for the treatment of diabetes

The patent which is assigned to the University of Pittsburgh has been exclusively licensed to PRP. The drug, known as PulmoLAR, containing 2ME as active ingredient, is currently developed by PRP for the treatment of pulmonary arterial hypertension (PAH).

North American legal injection drug site helps decrease overdose deaths, study shows

North America's only authorized facility for injecting illegal drugs has helped cut drug overdose deaths significantly in the Vancouver community where it is located and "should be used as a model in other cities," according to a study published on Monday in the Lancet, Reuters reports (Dowd, 4/18).

Read more Medical News

› Verified 3 days ago

• 1
• 2(current)